(S)-6-甲基-2-((S)-4-甲基环己-3-烯-1-基)庚-5-烯-2-醇

中文名称：(S)-6-甲基-2-((S)-4-甲基环己-3-烯-1-基)庚-5-烯-2-醇
CAS号：23089-26-1
中文别名：左旋没药醇;(-)-α-红没药醇;(-)-Alpha-没药醇;（-）-α-没药醇;[S-(R*,R*)]-α’-4-二甲基-α’-(4-甲基-3-戊烯基)-3-环己烯-1-甲醇;[S-(R*,R*)]-α'-4-二甲基-α'-(4-甲基-3-戊烯基)-3-环己烯-1-甲醇;a-(-)-没药醇(P);α-(-)-没药醇;红没药醇标准品;左美诺醇 USP标准品;[S-(R*,R*)]-Alpha’-4-二甲基-Alpha’-(4-甲基-3-戊烯基)-3-环己烯-1-甲醇;左旋甜没药醇;(-)-6-甲基-2-(4-甲基-3-环己烯-1-基)-5-庚烯-2-醇;左美诺醇;alpha-(-)-甜没药醇
英文名称：Levomenol
英文别名：Levomenol;(-)-alpha-Bisabolol;(−)-α-Bisabolol;3-Cyclohexene-1-methanol,a,4-dimethyl-a-(4-methyl-3-penten-1-yl)-, (aS,1S)-;ALPHA-(-)-BISABOLOL;BISABOLOL, a-(-)-(SG);(?)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol,Levomenol;(?)-α-Bisabolol;BISABOLOL;Camilol;Levomenlol;(alphaS,1S)-alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol;(-)-(1'S,2S)-alpha-Bisabolol;(-)-(4S,8S)-alpha-Bisabolol;Kamillosan;l-alpha-Bisabolol;(-)-α-Bisabolol;levomenol;CAS-23089-26-1;MFCD03412455;(-)-alpha-Bisabolol, >=93% (GC);LEVOMENOL (USP-RS);Dragosantol;Kamilosan;Levomenol [INN];l-.alpha.-Bisabolol;Dragosantol (>80%);J-014978;DTXSID4042094;PurpleU BAOBAB FACE;Levomenol 100 microg/mL in Methanol;5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL), (-)-;[S-(R*,R*)]-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol;RACEMIC ALFA-BISABOLOL;LMPR0103060001;Levomenolum;alpha-BISABOLOL, (-)-;CCRIS 9081;ALPHA-(-)BISABOLOL;(-)-;BISABOLOL, ALPHA;3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R*,R*)]-;BDBM50382730;Hydagen B;NCGC00255987-01;alpha-Bisabolol;3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-;DTXCID2022094;3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaS,1S)-;CHEBI:125;3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.S,1S)-;Levomenol, United States Pharmacopeia (USP) Reference Standard;(2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol;BISABOLOL [INCI];[S-(R*,R*)]-.alpha.-Bisabolol;alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphaS,1S)-3-Cyclohexene-1-methanol;(-)- alpha -Bisabolol;LEVOMENOL (MART.);(-)-alpha-Bisabolol, primary pharmaceutical reference standard;NSC-782530;Levomenol; (-)-?-Bisabolol;A-Bisabolol;Levomenol, INN;NS00068750;LEVOMENOL [USP-RS];(-)-.ALPHA.-BISABOLOL (CONSTITUENT OF CHAMOMILE) [DSC];Levomenolum (INN-Latin);Bisbalol;Q179896;(-)-Alpha-bisabolol(-)-alpha-bisabolol;1-alpha-Bisabolol;alpha-(-)-Bisabolol;.alpha.-Bisabolol (-)-form;CS-0028206;LEVOMENOL [WHO-DD];5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-;23089-26-1;(-)-a-Bisabolol;(-)-alpha-Bisabolol, analytical standard;(alphaS,1S)-alpha-BISABOLOL;Levomenolum [INN-Latin];3-CYCLOHEXENE-1-METHANOL, alpha,4-DIMETHYL-alpha-(4-METHYL-3-PENTEN-1-YL)-, (alphaS,1S)-;.ALPHA.-BISABOLOL (-)-FORM [MI];(S)-6-Methyl-2-((S)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol;Tox21_301375;alpha-Bisabolol (-)-form;L-alpha-Bisabolol;alpha-Bisabolol, L-;3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-,(aS,1S)-;.alpha.-Bisabolol;3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL-3-PENTEN-1-YL)-, (.ALPHA.S,1S)-;Bisabolol, (-)-.alpha.;(-)-.alpha.-Bisabolol;515-69-5;BISABOLOL [VANDF];((-))-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol;EINECS 245-423-3;Bisabolol;UN...
EINEC:208-205-9
分子式：C15H26O
分子量：222.36634